JOHN F KESSLER MD NPI 1598760274

NPI Information

  • NPI: 1598760274
  • Provider Name: JOHN F KESSLER, MD
  • Classification: Specialist - 174400000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1051 LOFTIS BLVD
    SUITE 100
    NEWPORT NEWS, VA
    ZIP 23606
  • Phone: (757) 873-9400

Map and Directions

Get Directions

NPI Details

John F Kessler, MD is a specialist in Newport News, VA with 49 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. John F Kessler, MD NPI is 1598760274. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1977

The provider's business location address is:

1051 LOFTIS BLVD
SUITE 100
NEWPORT NEWS, VA
ZIP 23606-069
Phone: (757) 873-9400
Fax: (757) 873-9420

The NPI 1598760274 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Unclassified drugs (HCPCS:J3490)
  • Vitamin d-3 level (HCPCS:82306)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Urinalysis, manual test (HCPCS:81002)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)

The enumeration date for this NPI number is 6/17/2005 and was last updated on 4/12/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialist0101045128VIRGINIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1110054753OTHERVIRGINIARAILROAD MEDICARE
255095OTHERVIRGINIAOPTIMA
3E67349MEDICARE UPINVIRGINIA
4110005856MEDICARE PINVIRGINIA
5006036384MEDICAIDVIRGINIA
6830003009MEDICARE PINVIRGINIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.